<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319712455497</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319712455497</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics and Vascular Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of Adiponectin Gene Polymorphism (+T45G) With Acute Coronary Syndrome and Circulating Adiponectin Levels</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rizk</surname>
<given-names>Nasser M.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0003319712455497">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319712455497"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>El-Menyar</surname>
<given-names>Ayman</given-names>
</name>
<degrees>MBchB, MSc, FRCP, FESC, FACC</degrees>
<xref ref-type="aff" rid="aff2-0003319712455497">2</xref>
<xref ref-type="aff" rid="aff3-0003319712455497">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marei</surname>
<given-names>Isra</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff1-0003319712455497">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sameer</surname>
<given-names>Maha</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff1-0003319712455497">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Musad</surname>
<given-names>Tasneem</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff1-0003319712455497">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Younis</surname>
<given-names>Dima</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff1-0003319712455497">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Farag</surname>
<given-names>Fathi</given-names>
</name>
<degrees>MBchB, MD</degrees>
<xref ref-type="aff" rid="aff4-0003319712455497">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Basem</surname>
<given-names>Nora</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff5-0003319712455497">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al-Ali</surname>
<given-names>Khalid</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0003319712455497">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suwaidi</surname>
<given-names>Jassim Al</given-names>
</name>
<degrees>MBchB, FESC, FACC</degrees>
<xref ref-type="aff" rid="aff2-0003319712455497">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0003319712455497">
<label>1</label>Health Sciences, College of Arts and Sciences, Qatar University, Doha, Qatar</aff>
<aff id="aff2-0003319712455497">
<label>2</label>Cardiology Department, Heart Hospital, Hamad Medical Corporation (HMC), Doha, Qatar</aff>
<aff id="aff3-0003319712455497">
<label>3</label>Clinical Medicine, Weill Cornell Medical School, Doha, Qatar</aff>
<aff id="aff4-0003319712455497">
<label>4</label>Al Emadi Hospital, Doha, Qatar</aff>
<aff id="aff5-0003319712455497">
<label>5</label>Clinical Chemistry Department, Hamad Medical Corporation, Doha, Qatar</aff>
<author-notes>
<corresp id="corresp1-0003319712455497">Nasser M. Rizk, Biomedical Science Program, Faculty of Science, College of Arts and Sciences, Qatar University, PO Box 2713, Doha, Qatar. Email: <email>nassrizk@qu.edu.qa</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>64</volume>
<issue>4</issue>
<fpage>257</fpage>
<lpage>265</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>We investigated the association of adiponectin gene polymorphisms (+T45G and +G276T) and adiponectin levels with acute coronary syndrome (ACS) among Arabs in Qatar. A case–control study was performed in 142 Arab patients with ACS and 122 controls. Genotypes were determined using TaqMan real-time polymerase chain reaction assay. The TT, TG, and GG genotype frequencies of the T45G variant were significantly different among cases and controls (<italic>P</italic> = .023) but not significant for G276T genotypic frequencies. It was found that only the +45G allele was significantly associated with 3-fold increased risk of ACS (odds ratio = 2.77; 1.03-6.96; <italic>P</italic> = .043) among patients, using the genetic recessive model. Carriers of GG alleles had significantly lower adiponectin levels compared to TT/TG carriers of T45G in patients with ACS. The present study suggests that only T45G single-nucleotide polymorphism in the adiponectin gene is associated with higher odds for ACS events and has an effect on serum adiponectin levels among Arab populations.</p>
</abstract>
<kwd-group>
<kwd>adiponectin</kwd>
<kwd>polymorphism</kwd>
<kwd>gene</kwd>
<kwd>acute coronary syndrome</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0003319712455497">
<title>Introduction</title>
<p>Adiponectin is a hormone secreted by adipocytes<sup>
<xref ref-type="bibr" rid="bibr1-0003319712455497">1</xref>
</sup> that has a number of antiatherogenic properties.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712455497">2</xref>
</sup> Adiponectin is thought to be extensively deposited in the interstitium of vascular lesions of patients with myocardial infarction (MI).<sup>
<xref ref-type="bibr" rid="bibr3-0003319712455497">3</xref>
</sup> In humans, a decreased adiponectin concentration may be a risk factor for atherosclerosis<sup>
<xref ref-type="bibr" rid="bibr1-0003319712455497">1</xref>,<xref ref-type="bibr" rid="bibr4-0003319712455497">4</xref>
</sup> and has been linked to the presence of coronary artery diseases (CADs).<sup>
<xref ref-type="bibr" rid="bibr5-0003319712455497">5</xref>
</sup> Adiponectin is the most abundant hormone circulating in the plasma (∼10-30 μg/mL or ∼0.01% of plasma proteins). It is present primarily in 3 forms: a low-molecular-weight (LMW) trimer of approximately 67 kDa, a hexamer of ∼120 kDa and a high-molecular-weight (HMW) multimer of &gt;300 kDa. The HMW form has been shown to possess the most potent insulin-sensitizing and anti-atherosclerotic effects. Defects in adiponectin level and its HMW form are associated with obesity, atherosclerosis, and cardiovascular disease (CVD).<sup>
<xref ref-type="bibr" rid="bibr6-0003319712455497">6</xref>
</sup> Moreover, plasma adiponectin concentrations are significantly lower in obese participants than in nonobeseparticipants.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712455497">1</xref>
</sup> Ostial coronary artery levels of adiponectin in acute coronary syndrome (ACS) may indicate redistribution of adiponectin molecules toward the acute lesions.<sup>
<xref ref-type="bibr" rid="bibr7-0003319712455497">7</xref>
</sup>
</p>
<p>The human adiponectin gene is located in chromosome 3q27 that is known to be the susceptibility locus for metabolic syndrome and type 2 diabetes mellitus (DM) and is encoded by 3 exons which span approximately 16 kb.<sup>
<xref ref-type="bibr" rid="bibr8-0003319712455497">8</xref>,<xref ref-type="bibr" rid="bibr9-0003319712455497">9</xref>
</sup> The genetic polymorphism of rs2241766 (+T45G) and rs1501299 (+G276T) in the exon 2 and intron 2 has been frequently associated with type 2 DM, obesity, and CAD.<sup>
<xref ref-type="bibr" rid="bibr10-0003319712455497">10</xref>
<xref ref-type="bibr" rid="bibr11-0003319712455497"/>
<xref ref-type="bibr" rid="bibr12-0003319712455497"/>
<xref ref-type="bibr" rid="bibr13-0003319712455497"/>–<xref ref-type="bibr" rid="bibr14-0003319712455497">14</xref>
</sup>
</p>
<p>A genetic deficit of this protein might increase the risk of ACS events in both the general population and type 2 diabetic patients especially with decreased HMW adiponectin/total adiponectin ratio.<sup>
<xref ref-type="bibr" rid="bibr7-0003319712455497">7</xref>
</sup> Two single-nucleotide polymorphisms (SNPs) at the adiponectin locus (T45G) and (G276T) have been associated with low serum adiponectin levels, insulin resistance, and DM.<sup>
<xref ref-type="bibr" rid="bibr10-0003319712455497">10</xref>,<xref ref-type="bibr" rid="bibr15-0003319712455497">15</xref>
</sup> Therefore, it could be postulated that these SNPs may also play a role in the development of MI and ACS through its effect on adiponectin biology.</p>
<p>This study was based on our previous finding that circulating adiponectin levels are lower in patients with ACS.<sup>
<xref ref-type="bibr" rid="bibr6-0003319712455497">6</xref>
</sup> Hence, we evaluated the association of adiponectin gene polymorphisms (T45G and G276T) and circulating adiponectin levels with the odds of ACS events among Arab population. We also assessed the association of these SNPs with the angiographic changes (number of blood vessels involved) and left ventricular ejection fraction (LVEF) among patients with ACS.</p>
</sec>
<sec id="section2-0003319712455497" sec-type="methods">
<title>Patients and Methods</title>
<sec id="section3-0003319712455497">
<title>Study Participants</title>
<p>A case–control study was performed in 264 unrelated Arab participants (142 patients with ACS and 122 controls), residing in Qatar, and the participants were enrolled for the study from March 2008 to May 2010. Participants with age ranging from 30 to 70 years (males or females) with a definite diagnosis of non-ST and ST elevation MI according to the American College of Cardiology criteria were included in the study. All patients were consecutively enrolled based on either symptoms consistent with acute MI or electrocardiographic changes in at least 2 contiguous leads and had serum markers of myocardial necrosis (creatine kinase MB and troponin) levels twice the upper limit of normal. The time from the onset of symptoms to admission to the intensive care unit had to be less than 24 hours. The control group included healthy volunteers who attended the blood bank of the Hamad General Hospital.</p>
<p>Participants with type 2 DM were diagnosed according to the World Health Organization (WHO) criteria.<sup>
<xref ref-type="bibr" rid="bibr16-0003319712455497">16</xref>
</sup> Dyslipidemia was diagnosed based on the criteria of National Cholesterol Education Program Adult Treatment Panel III.<sup>
<xref ref-type="bibr" rid="bibr17-0003319712455497">17</xref>
</sup> Hypertension was defined as a systolic and/or diastolic blood pressure (BP) ≥140 and/or ≥90 mm Hg, respectively, or a significant history of hypertension and/or under antihypertensive medication. The cutoff point for body mass index (BMI) was based on the WHO criteria.<sup>
<xref ref-type="bibr" rid="bibr18-0003319712455497">18</xref>
</sup> Individuals with other diseases such as cancer, autoimmune disorders, and advanced renal and liver complications were excluded. Informed consent was obtained from each participant after detailed explanation about the study. The institutional review board has approved the study.</p>
</sec>
<sec id="section4-0003319712455497">
<title>Clinical and Biochemical Investigations</title>
<p>Height, weight, systolic, and diastolic BP of the patients were measured by a trained professional in the clinic. Ten milliliters of peripheral blood were collected from each participant. Five milliliters were used for DNA extraction and the remaining 5 mL for determination of biochemical and hormonal parameters. Serum concentrations of total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), glucose, and cardiac markers were also measured. Serum insulin and adiponectin levels were measured by enzyme-linked immunosorbent assay (Millipore, MA, USA), according to the manufacturer’s instructions, in the Biomedical Laboratory, Department of Health Sciences, Qatar University. Left ventricular ejection fraction was determined at the cardiology department.</p>
</sec>
<sec id="section5-0003319712455497">
<title>Genomic DNA Isolation</title>
<p>DNA was extracted from venous blood samples of all cases and controls using QiaAmp DNA blood Mini Kit (Qiagen, Germany), with red blood cell lyses solution (Qiagen). DNA extraction was performed according to the manufacturer protocol. Measurements of DNA concentration and purity were assessed using nanodrop Spectrophotometer 1000 (Thermo Scientific, Wilmington, Delaware).</p>
</sec>
<sec id="section6-0003319712455497">
<title>Genotypic Characterization of Adiponectin (T45G and G276T) Gene Variants Using Real-Time Polymerase Chain Reaction</title>
<p>Based upon previous report,<sup>
<xref ref-type="bibr" rid="bibr19-0003319712455497">19</xref>
</sup> 2 tagged SNPs (T45G and G276T) in the adiponectin gene were selected for the present study. Analysis of these SNPs was carried out based on 5′ nuclease assay by TaqMan MGB probe using ABI 7500 (Applied Biosystems, Foster City, California). The primers and probes were obtained from assay-on demand TM service of Applied Biosystems. Briefly, the 5′ nuclease assay was performed using 20 ng genomic DNA, 1× TaqMan Universal PCR Master Mix (Applied Biosystems), 1× primer/probe mix, and optimal cycling conditions for polymerase chain reaction (PCR) amplification as provided by the manufacturer. Negative and positive controls were also included for quality controls.</p>
</sec>
</sec>
<sec id="section7-0003319712455497">
<title>Statistical Analysis</title>
<p>Data are expressed as mean and 95% confidence interval (CI) for continuous variables and by number and percentage for categorical data. All statistical analyses were performed using the SPSS program for Windows (version 19 statistical software; Texas instruments, Illinois) and Golden Helix’ SNP &amp; Variation Suite (SVS 7; Bozeman, Montana), for genetic analysis. Differences between continuous variables were evaluated accordingly by Student <italic>t</italic> test (2-tailed) and analysis of variance wherever applicable. Nonparametric Mann-Whitney and 2 independent samples <italic>t</italic> tests were used accordingly for analysis. Genotype distribution and allelic frequencies between the study groups were compared by constructing 2 × 2 contingency tables, and chi-square test (χ<sup>2</sup>) or Fischer exact test corrected for Bonferroni adjustment for the number of SNPs. The Hardy-Weinberg Equilibrium (HWE) was performed using χ<sup>2</sup> test to assess the genotype distribution in all study participants. Three genetic models, that is, dominant minor allele, recessive minor allele, and additive models (additional copy of the risk alleles increases the response by an equal amount) were analyzed. Odds ratio (ORs), 95% CI, and corresponding <italic>P</italic> values were analyzed by logistic regression analysis and adjusted accordingly. The ORs were computed using the minor allele homozygous as the reference group unless mentioned otherwise. A 2-tailed <italic>P</italic> &lt;.05 was considered significant.</p>
</sec>
<sec id="section8-0003319712455497">
<title>Results</title>
<sec id="section9-0003319712455497">
<title>Characteristics of Patient Population</title>
<p>Among 264 participants, 142 patients presented with ACS with a mean age of 53.5 (51.0-54.6 years), 91% were males, 25% were hypertensive, and 49% had DM. Dyslipidemia and BMI were comparable between the ACS and control groups (32% vs 27%, <italic>P</italic> = .58 and 28% vs 30%, <italic>P</italic> = .06, respectively). Serum insulin levels were higher in the ACS group (33.36 µU/mL; 27.35-39.37) compared with the control group (22.09 µU/mL; 12.06-32.12), whereas the serum adiponectin levels were lower in ACS group (7.00 µg/mL; 5.86-8.15) than in controls (9.35 µg/mL; 8.09-10.62, <italic>P</italic> = .01; <xref ref-type="table" rid="table1-0003319712455497">Table 1</xref>). Overall, the SNP genotypes and allelic frequencies were determined in 264 individuals. All examined <italic>AdipoQ</italic> gene polymorphisms were in HWE (<italic>P</italic> &gt; .05). For T45G, the <italic>P</italic> value of HWE was .244 and .152 and for G276T was 0.394 and 0.521 among control and cases, respectively. A significant difference was observed in genotypic distribution of T45G (<italic>P </italic>= .023; <xref ref-type="table" rid="table2-0003319712455497">Table 2</xref>) between ACS and control participants. However, the frequency of G276T genotypes was comparable among cases and controls (<italic>P</italic> = .982). Moreover, the genotypic distribution of <italic>AdipoQ</italic> gene polymorphisms (T45G and G276T) was not statistically different among patients with ACS based on the presence of DM and the number of obstructive coronary arteries (<xref ref-type="fig" rid="fig1-0003319712455497">Figures 1</xref> and <xref ref-type="fig" rid="fig2-0003319712455497">2</xref>). <xref ref-type="fig" rid="fig3-0003319712455497">Figure 3</xref> shows the distribution of T45G polymorphism according to LVEF. There was a trend for more GG genotype among patients with lower LVEF (&lt;40%). The genotypic distribution of <italic>AdipoQ</italic> gene polymorphisms (T45G and G276T) was not statistically different among patients with ACS based on gender, hypertension, hypertriglyceridemia, low HDL-C, high LDL-C, and hypercholesterolemia (<xref ref-type="table" rid="table3-0003319712455497">Table 3</xref>).</p>
<table-wrap id="table1-0003319712455497" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical and Biochemical Data of Patients With Acute Coronary Syndrome (ACS) and Controls.<sup><xref ref-type="table-fn" rid="table-fn2-0003319712455497">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table1-0003319712455497" xlink:href="10.1177_0003319712455497-table1.tif"/>
<table>
<thead>
<tr>
<th>Variables</th>
<th>ACS, n = 142</th>
<th>Controls, n = 122</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, years</td>
<td>53.5 (51.0-54.6)</td>
<td>35.0 (26.4-33.6) </td>
<td>.001</td>
</tr>
<tr>
<td>Gender: male/female</td>
<td>131 (91.5%)/11 (7.5%)</td>
<td>106 (86.9%)/16.0 (13.1%)</td>
<td>.089</td>
</tr>
<tr>
<td>BMI, kg/m<sup>2</sup>
</td>
<td>27.7 (26.5-28.9)</td>
<td>29.8 (27.9-31.7)</td>
<td>.064</td>
</tr>
<tr>
<td>Hypertension</td>
<td>35 (24.6%)</td>
<td align="center">–</td>
<td>
</td>
</tr>
<tr>
<td>Diabetes mellitus</td>
<td>70.0 (49.3%)</td>
<td align="center">–</td>
<td>
</td>
</tr>
<tr>
<td>Dyslipidemia </td>
<td>45.0 (31.7%)</td>
<td>33.0 (27.1%)</td>
<td>.586</td>
</tr>
<tr>
<td>Glucose, mmol/L</td>
<td>8.2 (7.3-9.1)</td>
<td>5.3 (4.3-6.3)</td>
<td>.001</td>
</tr>
<tr>
<td>LDL, mmol/L</td>
<td>3.1 (2.9-3.3)</td>
<td>2.7 (2.5-2.9)</td>
<td>.015</td>
</tr>
<tr>
<td>HDL, mmol/L</td>
<td>1.6 (0.4-2.8)</td>
<td>2.0 (0.6-3.3)</td>
<td>.698</td>
</tr>
<tr>
<td>TC, mmol/L</td>
<td>8.0 (2.5-13.6)</td>
<td>5.0 (1.1-11.1)</td>
<td>.522</td>
</tr>
<tr>
<td>TG, mmol/L</td>
<td>2.1 (1.5-2.7)</td>
<td>1.8 (1.0-2.3)</td>
<td>.370</td>
</tr>
<tr>
<td>Insulin, µmol/L</td>
<td>33.4 (27.3-39.4)</td>
<td>22.1 (12.1-32.1)</td>
<td>.041</td>
</tr>
<tr>
<td>Adiponectin, µg/mL</td>
<td>7.00 (5.86-8.15)</td>
<td>9.35 (8.09-10.62)</td>
<td>.017</td>
</tr>
<tr>
<td>Troponin, ng/mL</td>
<td>5.98 (4.64-7.32)</td>
<td align="center">–</td>
<td>
</td>
</tr>
<tr>
<td>CK-MB, ng/mL</td>
<td>161 (132-190)</td>
<td align="center">–</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0003319712455497">
<p>Abbreviations: BMI, body mass index; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; CK-MB, creatine kinase MB protein.</p>
</fn>
<fn id="table-fn2-0003319712455497">
<p>
<sup>a</sup> Continuous data are presented as means (95% confidence interval). Categorical variables are presented as number (percentage). Mean difference in glucose, LDL, HDL, TC, TG, insulin, and adiponectin are adjusted for age, gender, and BMI.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table2-0003319712455497" position="float">
<label>Table 2.</label>
<caption>
<p>Genotype Distribution of Adiponectin Gene Polymorphisms (+45T&gt;G and +276G&gt;T) in Patients With ACS and Controls.</p>
</caption>
<graphic alternate-form-of="table2-0003319712455497" xlink:href="10.1177_0003319712455497-table2.tif"/>
<table>
<thead>
<tr>
<th>SNP Variant</th>
<th>Genotype</th>
<th>ACS, n = 142 (%)</th>
<th>Controls, n = 122 (%)</th>
<th>
<italic>P</italic>
</th>
<th>χ<sup>2</sup>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>+45T&gt;G</td>
<td>G/G</td>
<td>38 (26.76)</td>
<td>17 (13.93)</td>
<td>.023<sup><xref ref-type="table-fn" rid="table-fn4-0003319712455497">a</xref></sup>
</td>
<td>7.553</td>
</tr>
<tr>
<td>
</td>
<td>T/G</td>
<td>42 (29.58)</td>
<td>49 (40.16)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
</td>
<td>T/T</td>
<td>62 (43.66)</td>
<td>56 (45.91)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>+276G&gt;T</td>
<td>G/G</td>
<td>58 (40.85)</td>
<td>46 (38.02)</td>
<td>.982</td>
<td>0.037</td>
</tr>
<tr>
<td>
</td>
<td>G/T</td>
<td>64 (45.07)</td>
<td>59 (48.76)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
</td>
<td>T/T</td>
<td>20 (14.08)</td>
<td>16 (13.22)</td>
<td>
</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0003319712455497">
<p>Abbreviations: ACS, acute coronary syndrome; SNP, single-nucleotide polymorphism.</p>
</fn>
<fn id="table-fn4-0003319712455497">
<p>
<sup>a</sup> <italic>P</italic> &lt; .05 is considered statistically significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0003319712455497" position="float">
<label>Table 3.</label>
<caption>
<p>Genotype Distribution Based on Gender, Hypertension, and Lipid Profile.<sup><xref ref-type="table-fn" rid="table-fn6-0003319712455497">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table3-0003319712455497" xlink:href="10.1177_0003319712455497-table3.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">SNP Variant</th>
<th rowspan="2">Genotype</th>
<th colspan="2">Gender </th>
<th rowspan="2">
<italic>P</italic>
</th>
<th rowspan="2">χ<sup>2</sup>
</th>
</tr>
<tr>
<th>Males</th>
<th>Females</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="3">45T&gt;G</td>
<td>G/G</td>
<td>58 (26.76)</td>
<td>4 (13.93)</td>
<td>.736</td>
<td>0.612</td>
</tr>
<tr>
<td>T/G</td>
<td>38 (29.58)</td>
<td>4 (40.16)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>T/T</td>
<td>36 (43.66)</td>
<td>2 (45.91)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">276G&gt;T </td>
<td>G/G</td>
<td>53 (40.85)</td>
<td>4 (38.02)</td>
<td>.703</td>
<td>1.409</td>
</tr>
<tr>
<td>G/T</td>
<td>60 (45.07)</td>
<td>5 (48.76)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>T/T</td>
<td>19 (14.08)</td>
<td>1 (13.22)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="2">
</td>
<td rowspan="2">
</td>
<td colspan="2">HTN</td>
<td rowspan="2"> </td>
<td rowspan="2">
</td>
</tr>
<tr>
<td>No</td>
<td>Yes</td>
</tr>
<tr>
<td rowspan="3">45T&gt;G</td>
<td>G/G</td>
<td>37 (37.37)</td>
<td>21 (48.84)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>T/G</td>
<td>33 (33.33)</td>
<td>11 (25.58)</td>
<td>.544</td>
<td>1.218</td>
</tr>
<tr>
<td>T/T</td>
<td>29 (29.29)</td>
<td>11 (25.58)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">276G&gt;T</td>
<td>G/G</td>
<td>43 (43.43)</td>
<td>13 (30.23)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>G/T</td>
<td>44 (44.44)</td>
<td>21 (48.84)</td>
<td>.120</td>
<td>0.528</td>
</tr>
<tr>
<td>T/T</td>
<td>12 (12.12)</td>
<td>9 (20.93)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="2">
</td>
<td rowspan="2"> </td>
<td align="center" colspan="2">Hypercholesterolemia</td>
<td rowspan="2"> </td>
<td rowspan="2"> </td>
</tr>
<tr>
<td>No</td>
<td>Yes</td>
</tr>
<tr>
<td rowspan="3">45T&gt;G</td>
<td>G/G</td>
<td>43 (54.43)</td>
<td>20 (31.75)</td>
<td>.054</td>
<td>3.078</td>
</tr>
<tr>
<td>T/G</td>
<td>20 (25.32)</td>
<td>21 (33.33)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>T/T</td>
<td>16 (20.25)</td>
<td>22 (34.92)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">276G&gt;T</td>
<td>G/G</td>
<td>28 (35.45)</td>
<td>28 (44.44)</td>
<td>.406</td>
<td>0.910</td>
</tr>
<tr>
<td>G/T</td>
<td>41 (51.89)</td>
<td>23 (36.51)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>T/T</td>
<td>10 (12.66)</td>
<td>12 (19.05)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="2"> </td>
<td rowspan="2"> </td>
<td align="center" colspan="2">Hypertriglyceridemia</td>
<td rowspan="2"> </td>
<td rowspan="2"> </td>
</tr>
<tr>
<td>No</td>
<td>Yes</td>
</tr>
<tr>
<td rowspan="3">45T&gt;G</td>
<td>G/G</td>
<td>40 (44.44)</td>
<td>21 (40.38)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>T/G</td>
<td>25 (27.78)</td>
<td>17 (32.69)</td>
<td>.503</td>
<td>2.350</td>
</tr>
<tr>
<td>T/T</td>
<td>25 (27.78)</td>
<td>14 (26.92)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">276G&gt;T</td>
<td>G/G</td>
<td>34 (37.78)</td>
<td>22 (42.31)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>G/T</td>
<td>41 (45.56)</td>
<td>22 (42.31)</td>
<td>.212</td>
<td>3.502</td>
</tr>
<tr>
<td>T/T</td>
<td>15 (16.67)</td>
<td>8 (15.38)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="2">
</td>
<td rowspan="2"> </td>
<td colspan="2">HDL-C</td>
<td rowspan="2"> </td>
<td rowspan="2"> </td>
</tr>
<tr>
<td>No</td>
<td>Yes</td>
</tr>
<tr>
<td rowspan="3">45T&gt;G</td>
<td>G/G</td>
<td>27 (40.30)</td>
<td>36 (48.00)</td>
<td>.442</td>
<td>2.812</td>
</tr>
<tr>
<td>T/G</td>
<td>19 (28.36)</td>
<td>22 (29.33)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>T/T</td>
<td>21 (31.34)</td>
<td>17 (22.67)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">276G&gt;T </td>
<td>G/G</td>
<td>28 (41.79)</td>
<td>29 (38.67)</td>
<td>.111</td>
<td>3.009</td>
</tr>
<tr>
<td>G/T</td>
<td>26 (38.81)</td>
<td>37 (49.33)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>T/T</td>
<td>13 (19.40)</td>
<td>9 (12.00)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="2"> </td>
<td rowspan="2"> </td>
<td colspan="2">LDL-C</td>
<td rowspan="2"> </td>
<td rowspan="2"> </td>
</tr>
<tr>
<td>No</td>
<td>Yes</td>
</tr>
<tr>
<td rowspan="3">45T&gt;G</td>
<td>G/G</td>
<td>37 (45.68)</td>
<td>25 (40.98)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>T/G</td>
<td>22 (27.16)</td>
<td>19 (31.15)</td>
<td>.786</td>
<td>1.063</td>
</tr>
<tr>
<td>T/T</td>
<td>22 (27.16)</td>
<td>17 (27.87)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">276G&gt;T</td>
<td>G/G</td>
<td>29 (35.80)</td>
<td>27 (44.26)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>G/T</td>
<td>42 (51.85)</td>
<td>24 (39.35)</td>
<td>.212</td>
<td>3.502</td>
</tr>
<tr>
<td>T/T</td>
<td>10 (12.35)</td>
<td>10 (16.39)</td>
<td>
</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0003319712455497">
<p>Abbreviations: HTN, hypertension; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.</p>
</fn>
<fn id="table-fn6-0003319712455497">
<p>
<sup>a</sup> Data are presented as number and (percentage). <italic>P</italic> value is significant at &lt;.05. χ<sup>2</sup> = chi-square with 1 degree of freedom. Hypercholesterolemia based on cutoff value of desirable level of 5.18 mmol/L (no = below, yes = above this value), and for LDL-C on cutoff value of 3.37 mmol/L (no = below, yes = above this value). Both TG and HDL-C are based on clinical criteria for metabolic syndrome for TG = 1.695 mmol/L and for HDL-C (males = 1.036 mmol/L and females = 1.295 mmol/L) with no = below; yes = above this value.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig1-0003319712455497" position="float">
<label>Figure 1.</label>
<caption>
<p>Genotype distribution of T45G and G276T polymorphisms in patients with acute coronary syndrome (ACS) with (ACS + DM) and without diabetes (ACS − DM). DM indicates diabetes mellitus.</p>
</caption>
<graphic xlink:href="10.1177_0003319712455497-fig1.tif"/>
</fig>
<fig id="fig2-0003319712455497" position="float">
<label>Figure 2.</label>
<caption>
<p>Genotype distribution of T45G and G276T polymorphisms in acute coronary syndrome (ACS) according to the number of blood vessels affected.</p>
</caption>
<graphic xlink:href="10.1177_0003319712455497-fig2.tif"/>
</fig>
<fig id="fig3-0003319712455497" position="float">
<label>Figure 3.</label>
<caption>
<p>Genotype distribution of T45G and G276T polymorphisms in patients with acute coronary syndrome (ACS) based upon ejection fraction above and below 40.0%.</p>
</caption>
<graphic xlink:href="10.1177_0003319712455497-fig3.tif"/>
</fig>
</sec>
<sec id="section10-0003319712455497">
<title>Association Between ACS and Adiponectin Gene Polymorphism (T45G and G276T) Based on Genetic Models</title>
<p>The minor allele frequency (G allele) for T45G was 0.340 and 0.415 between control and patients with ACS, respectively. The minor allele frequency (T allele) for G276T was 0.376 and 0.365 in control and patients with ACS, respectively. Using the recessive genetic model for T45G (GG/TG+TT), carriers of GG genotype had an increased risk of ACS event by 2.8-fold (1.03-6.96, <italic>P </italic>= .043). In addition using the additive genetic models (GG+TG/TT), the G allele carriers had no significant risk of ACS event. Furthermore, GG/TT genotype had significant odds of 2 times for ACS (unadjusted OR [aOR] = 2.08; 0.02-0.69; <italic>P </italic>= .042) and GG/TG had a 4-fold increased risk of ACS (aOR = 3.85; 1.10-13.49; <italic>P </italic>= .035), as shown in <xref ref-type="table" rid="table4-0003319712455497">Table 4.</xref> On the other hand, no significant association was observed for G276T polymorphism for TT carriers compared with GG/TG alleles with respect to the risk of ACS events among study participants under different genetic models (<xref ref-type="table" rid="table4-0003319712455497">Table 4</xref>).</p>
<table-wrap id="table4-0003319712455497" position="float">
<label>Table 4.</label>
<caption>
<p>Risk Analysis of Adiponectin Gene Polymorphisms (T45G and G276T) According to Genotype Models Among ACS Cases and Controls.<sup><xref ref-type="table-fn" rid="table-fn8-0003319712455497">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table4-0003319712455497" xlink:href="10.1177_0003319712455497-table4.tif"/>
<table>
<thead>
<tr>
<th>SNPs</th>
<th>ACS Versus Controls (Genotype Models)</th>
<th>Odds Ratio (95% CI)</th>
<th>
<italic>P</italic>
</th>
<th>Adjusted Odds Ratio (95% CI)</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>+T45G</td>
<td>GG/TG+TT</td>
<td>2.235 (1.18-4.21)</td>
<td>.017</td>
<td>2.77 (1.03-6.96)</td>
<td>.043</td>
</tr>
<tr>
<td>
</td>
<td>GG+TG/TT</td>
<td>1.109 (0.68-1.80)</td>
<td>.771</td>
<td>1.23 (0.49-3.11)</td>
<td>.658</td>
</tr>
<tr>
<td>
</td>
<td>GG/TT</td>
<td>2.02 (1.03-3.97)</td>
<td>.042</td>
<td>2.08 (0.72-5.98)</td>
<td>.176</td>
</tr>
<tr>
<td>
</td>
<td>GG/TG</td>
<td>2.68 (1.29-5.28)</td>
<td>.008</td>
<td>3.85 (1.10-13.49)</td>
<td>.035</td>
</tr>
<tr>
<td>+G276T</td>
<td>TT/TG+GG</td>
<td>1.040 (0.51-2.13)</td>
<td>.914</td>
<td>0.59 (1.54-2.25)</td>
<td>.437</td>
</tr>
<tr>
<td>
</td>
<td>TT+TG/GG</td>
<td>0.968 (0.59-1.59)</td>
<td>.900</td>
<td>0.43 (0.17-1.08)</td>
<td>.073</td>
</tr>
<tr>
<td>
</td>
<td>TT/GG</td>
<td>0.997 (0.462-2.15)</td>
<td>.993</td>
<td>0.39 (0.09-1.64)</td>
<td>.199</td>
</tr>
<tr>
<td>
</td>
<td>TT/TG</td>
<td>1.046 (0.493-2.22)</td>
<td>.907</td>
<td>0.85 (0.21-3.51)</td>
<td>.835</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-0003319712455497">
<p>Abbreviations: ACS, acute coronary syndrome; SNP, single nucleotide polymorphism; BMI, body mass index; LDL-C, low-density lipoprotein cholesterol; 95% CI, 95% confidence interval.</p>
</fn>
<fn id="table-fn8-0003319712455497">
<p>
<sup>a</sup> <italic>P</italic> &lt; .05 is considered significant. Odds ratios are adjusted for age, BMI gender, LDL-C, glucose, insulin and adiponectin.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-0003319712455497">
<title>Serum Adiponectin Level and SNPT45G and G276T Among Patients With ACS</title>
<p>
<xref ref-type="fig" rid="fig4-0003319712455497">Figure 4</xref> shows that patients with GG genotypes of T45G polymorphism had a significantly lower serum adiponectin level compared with patients carrying TT and/or TG genotypes. No significant change in adiponectin level was detected among different genotypes for G276T polymorphisms. Furthermore, the recessive genetic model for T45G (<italic>P </italic>= .01 and β coefficient = −4.39) was the only significant determinant of adiponectin gene among patients with ACS (<xref ref-type="table" rid="table5-0003319712455497">Table 5</xref>). This independent factor explained 27% of the variation in the response variable (adiponectin) in ACS (<italic>P </italic>= .005) using this model. We analyzed the association between the serum adiponectin and the other significant variables (age, BMI, blood glucose, and HDL-C) included in the complete cohort of patients with ACS as the dependent variables and both SNPs as the independent variables. The results of multivariate correlations (<xref ref-type="fig" rid="fig4-0003319712455497">Figure 4</xref>) only showed a significant relationship between adiponectin as dependent variable and recessive genetic model for T45G as independent variables in patients with ACS.</p>
<fig id="fig4-0003319712455497" position="float">
<label>Figure 4.</label>
<caption>
<p>Serum adiponectin level based upon genotype distribution among T45G and G276T polymorphisms in patients with acute coronary syndrome (ACS). <italic>P</italic> value is significantly different than GG carriers (*, ∂) for T45G.</p>
</caption>
<graphic xlink:href="10.1177_0003319712455497-fig4.tif"/>
</fig>
<table-wrap id="table5-0003319712455497" position="float">
<label>Table 5.</label>
<caption>
<p>Multiple Regression Analysis of Serum Adiponectin Levels With Age, BMI, HDL, Glucose, and SNPs (+45T&gt;G and +276G&gt;T) Among Patients With ACS.<sup><xref ref-type="table-fn" rid="table-fn10-0003319712455497">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table5-0003319712455497" xlink:href="10.1177_0003319712455497-table5.tif"/>
<table>
<thead>
<tr>
<th>Risk Factor</th>
<th>β-Coefficient</th>
<th>Standard Coefficient</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age</td>
<td>0.111</td>
<td>0.071</td>
<td>.124</td>
</tr>
<tr>
<td>BMI</td>
<td>0.170</td>
<td>0.109</td>
<td>.123</td>
</tr>
<tr>
<td>HDL-C</td>
<td>0.878</td>
<td>1.368</td>
<td>.525</td>
</tr>
<tr>
<td>Glucose</td>
<td>0.132</td>
<td>0.145</td>
<td>.365</td>
</tr>
<tr>
<td>G276T </td>
<td>2.939</td>
<td>2.092</td>
<td>.164</td>
</tr>
<tr>
<td>T45G</td>
<td>−4.387</td>
<td>1.762</td>
<td>.015</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn9-0003319712455497">
<p>Abbreviations: ACS, acute coronary syndrome; BMI, body mass index; SNP, single nucleotide polymorphism; HDL-C, high-density lipoprotein cholesterol.</p>
</fn>
<fn id="table-fn10-0003319712455497">
<p>
<sup>a</sup> <italic>P</italic> &lt; .05 for levels of β-coefficient at 2-tailed testing.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section12-0003319712455497">
<title>Discussion</title>
<p>The present study reports adiponectin polymorphism among the Arab patients with ACS. The key findings are (i) there is a significant association of T45G SNP with a higher risk of having ACS for GG carriers, (ii) circulating adiponectin levels are significantly lower in GG genotypes of T45G among patients with ACS, (iii) no significant association of SNP G276T with ACS, (iv) there is no significant association DM, and number of blood vessels affected for both T45G and G276T polymorphism, and (v) LVEF is significantly different only according to the genotype distributions of T45G polymorphism in ACS. The implications of these findings are discussed below.</p>
<p>Among approximately 10 adiponectin gene polymorphisms reported until now, T45G was associated with the increased risk of insulin resistance and type 2 DM.<sup>
<xref ref-type="bibr" rid="bibr20-0003319712455497">20</xref>
<xref ref-type="bibr" rid="bibr21-0003319712455497"/>–<xref ref-type="bibr" rid="bibr22-0003319712455497">22</xref>
</sup> Several studies have demonstrated strong genetic associations between adiponectin and CVD.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712455497">1</xref>,<xref ref-type="bibr" rid="bibr2-0003319712455497">2</xref>,<xref ref-type="bibr" rid="bibr6-0003319712455497">6</xref>
</sup> In the present study, T to G mutation at T45G of adiponectin gene increases the odds of ACS even after adjustment for potential confounding factors. In contrast, the SNP G276T has no significant association of ACS events among the study participants. Considering the association of the SNP T45G with ACS, our findings are in agreement with other studies from French, Swiss, Iranian Saudi, and Afro-Caribbean involving type 2 diabetic patients.<sup>
<xref ref-type="bibr" rid="bibr12-0003319712455497">12</xref>,<xref ref-type="bibr" rid="bibr13-0003319712455497">13</xref>,<xref ref-type="bibr" rid="bibr23-0003319712455497">23</xref>,<xref ref-type="bibr" rid="bibr24-0003319712455497">24</xref>
</sup>
</p>
<p>Lacquemant and coworkers investigated the associations of 6 SNPs (−11377C&gt;G, −4041A&gt;C, +45T&gt;G, +276G&gt;T, +349A&gt;G, and +2019delA) with CAD in cohorts of French and Swiss type 2 diabetic patients. An association between the +45T&gt;G SNP and CAD was observed in both cohorts separately, as well as when the 2 groups were pooled.<sup>
<xref ref-type="bibr" rid="bibr23-0003319712455497">23</xref>
</sup> GG homozygotes and GT heterozygotes of +45T&gt;G combined presented an increased risk of CAD as compared to TT homozygotes (OR: 2.0; 95% CI: 1.3-3.2; <italic>P</italic> = .02).<sup>
<xref ref-type="bibr" rid="bibr23-0003319712455497">23</xref>
</sup> In addition, Boumaiza et al, among Tunisian population with significant coronary stenosis (SCS), demonstrated that mutated genotypes at +45T/G (GG+TG) were associated with an increase in SCS only in the obese group.<sup>
<xref ref-type="bibr" rid="bibr25-0003319712455497">25</xref>
</sup> The current data are consistent with the study by Al-Daghri et al which showed that SNP45T&gt;G of adiponectin gene was significantly associated with the risk of CAD (OR; 95% CI, 4.7; 1.6-13.5, <italic>P</italic> &lt; .003) but not SNP276G&gt;T (OR; 95% CI, 1.02; 0.53-1.9, <italic>P</italic> &gt; .05) among patients with type 2 DM in Saudi Arabia.<sup>
<xref ref-type="bibr" rid="bibr12-0003319712455497">12</xref>
</sup> Moreover, these studies reported a lack of an association of SNP G276T with CAD in Saudi patients with type 2 DM<sup><xref ref-type="bibr" rid="bibr12-0003319712455497">12</xref></sup> and in French and Swiss patients.<sup>
<xref ref-type="bibr" rid="bibr23-0003319712455497">23</xref>
</sup>
</p>
<p>Among Brazilians, the SNP45T&gt;G and SNP276G&gt;T polymorphisms were associated with CAD.<sup>
<xref ref-type="bibr" rid="bibr26-0003319712455497">26</xref>
</sup> Our data, however, contrast with other studies,<sup>
<xref ref-type="bibr" rid="bibr13-0003319712455497">13</xref>,<xref ref-type="bibr" rid="bibr27-0003319712455497">27</xref>,<xref ref-type="bibr" rid="bibr28-0003319712455497">28</xref>
</sup> which showed that SNP G276T had an association with the risk of CAD among type 2 diabetic patients. Esteghamati et al demonstrated that SNP+276G&gt;T is associated with decreased risk of CAD but not the +45T&gt;G SNP among Iranian patients with type 2 DM.<sup>
<xref ref-type="bibr" rid="bibr27-0003319712455497">27</xref>
</sup> Jang et al reported that the presence of the G allele in the adiponectin gene at SNP 276 could be a significant contributor to higher CVD risk in Koreans,<sup>
<xref ref-type="bibr" rid="bibr29-0003319712455497">29</xref>
</sup> while another study among Korean participants showed that +45T&gt;G and 276G&gt;T polymorphisms were not associated with CAD.<sup>
<xref ref-type="bibr" rid="bibr19-0003319712455497">19</xref>
</sup> In addition, a recent study by Pischon et al demonstrated that both +45T&gt;G and +276G&gt;T SNPs are not involved in the development of CAD.<sup>
<xref ref-type="bibr" rid="bibr30-0003319712455497">30</xref>
</sup> The inconsistency in these studies could be explained by the small sample size, ethnic background, or environmental factors.</p>
<p>The current data among patients with ACS showed no significant association of both +45T&gt;G and +276G&gt;T SNPs in the number of coronary vessels affected. A limited number of studies have addressed this association. A similar finding to our study showed no association for the blood vessels affected by the presence of CAD with the genotype distribution of +45T&gt;G and +276G&gt;T SNPs.<sup>
<xref ref-type="bibr" rid="bibr19-0003319712455497">19</xref>
</sup> In contrast, among Tunisian, the mutated genotypes at the +45T/G polymorphism were significantly associated with increased SCS only in obese patients.<sup>
<xref ref-type="bibr" rid="bibr25-0003319712455497">25</xref>
</sup> To our knowledge, no single study has been conducted so far to investigate the association of LVEF among patients with ACS with +45T&gt;G and +276G&gt;T SNPs of the adiponectin gene. Further studies are needed to explore this relationship.</p>
<p>Lower levels of circulating adiponectin were reported in patients with ACS, CAD, and cardiovascular risk.<sup>
<xref ref-type="bibr" rid="bibr7-0003319712455497">7</xref>,<xref ref-type="bibr" rid="bibr31-0003319712455497">31</xref>
<xref ref-type="bibr" rid="bibr32-0003319712455497"/>
<xref ref-type="bibr" rid="bibr33-0003319712455497"/>
<xref ref-type="bibr" rid="bibr34-0003319712455497"/>–<xref ref-type="bibr" rid="bibr35-0003319712455497">35</xref>
</sup> Moreover, the association of <italic>AdipoQ</italic> SNPs with circulating adiponectin has been assessed in several studies.<sup>
<xref ref-type="bibr" rid="bibr14-0003319712455497">14</xref>,<xref ref-type="bibr" rid="bibr15-0003319712455497">15</xref>,<xref ref-type="bibr" rid="bibr36-0003319712455497">36</xref>
<xref ref-type="bibr" rid="bibr37-0003319712455497"/>–<xref ref-type="bibr" rid="bibr38-0003319712455497">38</xref>
</sup> In Japanese patients with type 2 DM, SNP+45 was associated with reduced adiponectin levels.<sup>
<xref ref-type="bibr" rid="bibr10-0003319712455497">10</xref>
</sup> In order to test the effects of +45T&gt;G and +276G&gt;T SNPs on adiponectin levels, we measured serum adiponectin in patients with ACS. T SNP+45T&gt;G was associated with decreased levels of adiponectin in patients with ACS. Previous studies also found significant associations between adiponectin levels and <italic>ADIPOQ</italic> variants<sup>
<xref ref-type="bibr" rid="bibr27-0003319712455497">27</xref>,<xref ref-type="bibr" rid="bibr36-0003319712455497">36</xref>,<xref ref-type="bibr" rid="bibr39-0003319712455497">39</xref>
</sup> in a meta-analysis for which more than 2000 individuals have been studied.<sup>
<xref ref-type="bibr" rid="bibr40-0003319712455497">40</xref>
</sup> In addition, Woo et al studied white and African American adolescents and found that the haplotypes formed by SNPs 45, 276, and 349 were associated with low adiponectin levels in Whites but not in African Americans.<sup>
<xref ref-type="bibr" rid="bibr41-0003319712455497">41</xref>
</sup>
</p>
<p>In the present study, serum adiponectin levels were reduced in carriers of GG alleles of T45G in patients with ACS and the data of multiple regression analysis demonstrated that total adiponectin concentrations among ACS are associated with SNP T45G only. The T45G polymorphism located in exon 2 of the <italic>AdipoQ</italic> gene is suggested to be in linkage disequilibrium (LD) with other variants such as −1377 and −11391 SNPs of the 5/promoter region.<sup>
<xref ref-type="bibr" rid="bibr37-0003319712455497">37</xref>
</sup> Variations in the LD between populations may explain the inconsistent association with T45G SNP and adiponectin levels among different populations.<sup>
<xref ref-type="bibr" rid="bibr42-0003319712455497">42</xref>,<xref ref-type="bibr" rid="bibr43-0003319712455497">43</xref>
</sup> The SNP T45G could be a marker for a variant 3/UTR region via LD that could accelerate the degradation of messenger RNA (mRNA) with decreased adiponectin protein levels<sup>
<xref ref-type="bibr" rid="bibr44-0003319712455497">44</xref>
</sup> and/or that exonic SNP affects the mRNA splicing and changes the protein levels.<sup>
<xref ref-type="bibr" rid="bibr45-0003319712455497">45</xref>
</sup> Inconsistent with the current data, Mousavinasab et al showed that the T276T genotype of the adiponectin gene in young Finnish men was associated with elevated serum adiponectin but not T45G.<sup>
<xref ref-type="bibr" rid="bibr46-0003319712455497">46</xref>
</sup> The association of GG genotype with the marked decrease in total adiponectin levels in these patients may confer the increased odds of ACS events among patients carrying GG genotype of T45G.</p>
<p>The study has several limitations such as the relatively small number of patients, its cross-sectional nature, and less female participants. This small number of females does not reflect the number of women with ACS (in our cardiology unit) but reflects the number who consented.</p>
<p>In summary, we observed an association between the +45T&gt;G SNP with ACS and lower adiponectin concentrations especially among GG carriers. No significant association of G276T with ACS and adiponectin levels was observed. Both SNPs have no significant effect or association with affected blood vessels and LVEF in ACS. The assessment of <italic>AdipoQ</italic> gene polymorphism (T45G) with simultaneous measurement of total adiponectin may be helpful in detecting the risk of getting ACS among Arab patients, in conjunction with other clinical data.</p>
<p>Further studies are needed with larger samples to screen for polymorphism of the entire adiponectin gene and other genes. Subsequent functional studies of the identified SNPs will help understand the molecular mechanisms of any observed association.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We are grateful to the staff of Cardiology, Biochemistry and Medical Research center in Hamad Medical Corporation (HMC), Biomedical department, Qatar University and Alshafallah Genetic Center for their efforts and cooperation. Special thanks to Mrs Mooza Alkhinji, senior lab technician at Qatar University for her technical support. This publication was made possible by UREP grant number (4-3-42) from the Qatar National Research Fund (a member of Qatar Foundation). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1-0003319712455497">
<label>Authors’ Note</label>
<p>Part of this study was presented in The European Congress on Obesity: Annual Scientific Meeting, May 6-9, 2009, Amsterdam, the Netherlands.</p>
</fn>
<fn fn-type="conflict" id="fn2-0003319712455497">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0003319712455497">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Hamad Medical Research Center, HMC and Qatar University, Health Sciences, biomedical labs and sponsored by HMC and Qatar national research fund.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319712455497">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arita</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kihara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ouchi</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity</article-title>. <source>Biochem Biophys Res Commun</source>. <year>1999</year>;<volume>257</volume>(<issue>1</issue>):<fpage>79</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr2-0003319712455497">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouchi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kihara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arita</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin</article-title>. <source>Circulation</source>. <year>1999</year>;<volume>100</volume>(<issue>25</issue>):<fpage>2473</fpage>–<lpage>2476</lpage>.</citation>
</ref>
<ref id="bibr3-0003319712455497">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouchi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kihara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arita</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway</article-title>. <source>Circulation</source>. <year>2000</year>;<volume>102</volume>(<issue>11</issue>):<fpage>1296</fpage>–<lpage>1301</lpage>.</citation>
</ref>
<ref id="bibr4-0003319712455497">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kilaru</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Frangos</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>AH</given-names>
</name>
<etal/>
</person-group>. <article-title>Nicotine: a review of its role in atherosclerosis</article-title>. <source>J Am Coll Surg</source>. <year>2001</year>;<volume>193</volume>(<issue>5</issue>):<fpage>538</fpage>–<lpage>546</lpage>.</citation>
</ref>
<ref id="bibr5-0003319712455497">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kihara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sumitsuji</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of hypoadiponectinemia with coronary artery disease in men</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2003</year>;<volume>23</volume>(<issue>1</issue>):<fpage>85</fpage>–<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr6-0003319712455497">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Athyros</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Tziomalos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Karagiannis</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Should adipokines be considered in the choice of the treatment of obesity-related health problems?</article-title> <source>Curr Drug Targets</source>. <year>2010</year>;<volume>11</volume>(<issue>1</issue>):<fpage>122</fpage>–<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr7-0003319712455497">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Menyar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rizk</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Al Nabti</surname>
<given-names>AD</given-names>
</name>
<etal/>
</person-group>. <article-title>Total and high molecular weight adiponectin in patients with coronary artery disease</article-title>. <source>J Cardiovasc Med (Hagerstown)</source>. <year>2009</year>;<volume>10</volume>(<issue>4</issue>):<fpage>310</fpage>–<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr8-0003319712455497">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arita</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamagata</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Genomic structure and mutations in adipose-specific gene, adiponectin</article-title>. <source>Int J Obes Relat Metab Disord</source>. <year>2000</year>;<volume>24</volume>(<issue>7</issue>):<fpage>861</fpage>–<lpage>868</lpage>.</citation>
</ref>
<ref id="bibr9-0003319712455497">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vionnet</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hani</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Dupont</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24</article-title>. <source>Am J Hum Genet</source>. <year>2000</year>;<volume>67</volume>(<issue>6</issue>):<fpage>1470</fpage>–<lpage>1480</lpage>.</citation>
</ref>
<ref id="bibr10-0003319712455497">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Boutin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population</article-title>. <source>Diabetes</source>. <year>2002</year>;<volume>51</volume>(<issue>2</issue>):<fpage>536</fpage>–<lpage>540</lpage>.</citation>
</ref>
<ref id="bibr11-0003319712455497">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>YM</given-names>
</name>
<etal/>
</person-group>. <article-title>Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population</article-title>. <source>Diabet Med</source>. <year>2005</year>;<volume>22</volume>(<issue>5</issue>):<fpage>569</fpage>–<lpage>575</lpage>.</citation>
</ref>
<ref id="bibr12-0003319712455497">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Daghri</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Al-Attas</surname>
<given-names>OS</given-names>
</name>
<name>
<surname>Alokail</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Alkharfy</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes</article-title>. <source>Mol Biol Rep</source>. <year>2011</year>;<volume>38</volume>(<issue>6</issue>):<fpage>3703</fpage>–<lpage>3708</lpage>.</citation>
</ref>
<ref id="bibr13-0003319712455497">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabouri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghayour-Mobarhan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moohebati</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population</article-title>. <source>Scientific World J</source>. <year>2011</year>;<volume>11</volume>:<fpage>93</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr14-0003319712455497">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacci</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Menzaghi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ercolino</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients</article-title>. <source>Diabetes Care</source>. <year>2004</year>;<volume>27</volume>(<issue>8</issue>):<fpage>2015</fpage>–<lpage>2020</lpage>.</citation>
</ref>
<ref id="bibr15-0003319712455497">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menzaghi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ercolino</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Di Paola</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome</article-title>. <source>Diabetes</source>. <year>2002</year>;<volume>51</volume>(<issue>7</issue>):<fpage>2306</fpage>–<lpage>2312</lpage>.</citation>
</ref>
<ref id="bibr16-0003319712455497">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puavilai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chanprasertyotin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sriphrapradaeng</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria</article-title>. <source>World Health Organization. Diabetes Res Clin Pract</source>. <year>1999</year>;<volume>44</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr17-0003319712455497">
<label>17</label>
<citation citation-type="journal">
<collab collab-type="author">National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) </collab>
<article-title>Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>(<issue>25</issue>):<fpage>3143</fpage>–<lpage>3421</lpage>.</citation>
</ref>
<ref id="bibr18-0003319712455497">
<label>18</label>
<citation citation-type="journal">
<collab collab-type="author">WHO Technical Report Series G, WHO.</collab> <article-title>The use and interpretation of Anthropometry</article-title>. <source>WHO Expert Committee Physical Status</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>WHO</publisher-name>; <year>1995</year>:<fpage>854</fpage>.</citation>
</ref>
<ref id="bibr19-0003319712455497">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Rhee</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SY</given-names>
</name>
<etal/>
</person-group>. <article-title>Associations between two single nucleotide polymorphisms of adiponectin gene and coronary artery diseases</article-title>. <source>Endocr J</source>. <year>2006</year>;<volume>53</volume>(<issue>5</issue>):<fpage>671</fpage>–<lpage>677</lpage>.</citation>
</ref>
<ref id="bibr20-0003319712455497">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamauchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kadowaki</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans</article-title>. <source>Curr Diab Rep</source>. <year>2005</year>;<volume>5</volume>(<issue>2</issue>):<fpage>136</fpage>–<lpage>140</lpage>.</citation>
</ref>
<ref id="bibr21-0003319712455497">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menzaghi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Trischitta</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Doria</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease</article-title>. <source>Diabetes</source>. <year>2007</year>;<volume>56</volume>(<issue>5</issue>):<fpage>1198</fpage>–<lpage>1209</lpage>.</citation>
</ref>
<ref id="bibr22-0003319712455497">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese</article-title>. <source>J Genet Genomics</source>. <year>2009</year>;<volume>36</volume>(<issue>7</issue>):<fpage>417</fpage>–<lpage>423</lpage>.</citation>
</ref>
<ref id="bibr23-0003319712455497">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacquemant</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Froguel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lobbens</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Izzo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dina</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>The adiponectin gene SNP+45 is associated with coronary artery disease in type 2 (non-insulin-dependent) diabetes mellitus</article-title>. <source>Diabet Med</source>. <year>2004</year>;<volume>21</volume>(<issue>7</issue>):<fpage>776</fpage>–<lpage>781</lpage>.</citation>
</ref>
<ref id="bibr24-0003319712455497">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foucan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ezourhi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Maimaitiming</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descent</article-title>. <source>Obesity</source>. <year>2010</year>;<volume>18</volume>(<issue>7</issue>):<fpage>1466</fpage>–<lpage>1468</lpage>.</citation>
</ref>
<ref id="bibr25-0003319712455497">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boumaiza</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Omezzine</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rejeb</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Single-nucleotide polymorphisms at the adiponectin locus and risk of coronary artery disease in Tunisian coronaries</article-title>. <source>J Cardiovasc Med</source>. <year>2011</year>;<volume>12</volume>(<issue>9</issue>):<fpage>619</fpage>–<lpage>624</lpage>.</citation>
</ref>
<ref id="bibr26-0003319712455497">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Saddi-Rosa</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Crispim</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects</article-title>. <source>J Diabetes Complications</source>. <year>2012</year>;<volume>26</volume>(<issue>2</issue>):<fpage>94</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr27-0003319712455497">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esteghamati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mansournia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nakhjavani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mansournia</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Nikzamir</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abbasi</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes</article-title>. <source>Mol Biol Rep</source>. <year>2012</year>;<volume>39</volume>(<issue>4</issue>):<fpage>3791</fpage>–<lpage>3797</lpage>.</citation>
</ref>
<ref id="bibr28-0003319712455497">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filippi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sentinelli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Romeo</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>The adiponectin gene SNP+276G&gt; T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤ 50 years)</article-title>. <source>J Mol Med (Berl)</source>. <year>2005</year>;<volume>83</volume>(<issue>9</issue>):<fpage>711</fpage>–<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr29-0003319712455497">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>JS</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of the 276G-&gt;T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans</article-title>. <source>Am J Clin Nutr</source>. <year>2005</year>;<volume>82</volume>(<issue>4</issue>):<fpage>760</fpage>–<lpage>767</lpage>.</citation>
</ref>
<ref id="bibr30-0003319712455497">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pischon</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pai</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Manson</surname>
<given-names>JE</given-names>
</name>
<etal/>
</person-group>. <article-title>Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women</article-title>. <source>Obesity</source>. <year>2007</year>;<volume>15</volume>(<issue>8</issue>):<fpage>2051</fpage>–<lpage>2060</lpage>.</citation>
</ref>
<ref id="bibr31-0003319712455497">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fayyaz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>MZ</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Mehmood</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Akram</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghani</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Serum adiponectin levels in patients with coronary artery disease</article-title>. <source>J Ayub Med Coll</source>. <year>2009</year>;<volume>21</volume>(<issue>4</issue>):<fpage>90</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr32-0003319712455497">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yun</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Rhee</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>NJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Relationship between the echocardiographic epicardial adipose tissue thickness and serum adiponectin in patients with angina</article-title>. <source>J Cardiovasc Ultrasound</source>. <year>2009</year>;<volume>17</volume>(<issue>4</issue>):<fpage>121</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr33-0003319712455497">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otsuka</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men</article-title>. <source>Circ J</source>. <year>2007</year>;<volume>71</volume>(<issue>11</issue>):<fpage>1703</fpage>–<lpage>1709</lpage>.</citation>
</ref>
<ref id="bibr34-0003319712455497">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Sheu</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WL</given-names>
</name>
<etal/>
</person-group>. <article-title>Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris</article-title>. <source>Int J Cardiol</source>. <year>2008</year>;<volume>129</volume>(<issue>1</issue>):<fpage>76</fpage>–<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr35-0003319712455497">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizk</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Awni</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Osman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zirai</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Hypoadiponectinemia in obese and diabetic subjects in state of Qatar</article-title>. <source>Int J Diabetes Metab</source>. <year>2008</year>;<volume>16</volume>:<fpage>123</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr36-0003319712455497">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heid</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Gohlke</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians</article-title>. <source>Diabetes</source>. <year>2006</year>;<volume>55</volume>(<issue>2</issue>):<fpage>375</fpage>–<lpage>384</lpage>.</citation>
</ref>
<ref id="bibr37-0003319712455497">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasseur</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Helbecque</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dina</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians</article-title>. <source>Hum Mol Genet</source>. <year>2002</year>;<volume>11</volume>(<issue>21</issue>):<fpage>2607</fpage>–<lpage>2614</lpage>.</citation>
</ref>
<ref id="bibr38-0003319712455497">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rimm</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men</article-title>. <source>Diabetes</source>. <year>2005</year>;<volume>54</volume>(<issue>5</issue>):<fpage>1607</fpage>–<lpage>1610</lpage>.</citation>
</ref>
<ref id="bibr39-0003319712455497">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hivert</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Manning</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>McAteer</surname>
<given-names>JB</given-names>
</name>
<etal/>
</person-group>. <article-title>Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study</article-title>. <source>Diabetes</source>. <year>2008</year>;<volume>57</volume>(<issue>12</issue>):<fpage>3353</fpage>–<lpage>3359</lpage>.</citation>
</ref>
<ref id="bibr40-0003319712455497">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Din</surname>
</name>
<name>
<surname>g</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Association of ADIPOQ gene polymorphisms and coronary artery disease risk: a meta-analysis based on 12 465 subjects</article-title>. <source>Thromb Res</source>. <year>2012</year>;<volume>130</volume>(<issue>1</issue>):<fpage>58</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr41-0003319712455497">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woo</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Dolan</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Deka</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin</article-title>. <source>Diabetes</source>. <year>2006</year>;<volume>55</volume>(<issue>2</issue>):<fpage>523</fpage>–<lpage>529</lpage>.</citation>
</ref>
<ref id="bibr42-0003319712455497">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comuzzie</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Funahashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sonnenberg</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2001</year>;<volume>86</volume>(<issue>9</issue>):<fpage>4321</fpage>–<lpage>4325</lpage>.</citation>
</ref>
<ref id="bibr43-0003319712455497">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindsay</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Funahashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Krakoff</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Genome-wide linkage analysis of serum adiponectin in the Pima Indian population</article-title>. <source>Diabetes</source>. <year>2003</year>;<volume>52</volume>(<issue>9</issue>):<fpage>2419</fpage>–<lpage>2425</lpage>.</citation>
</ref>
<ref id="bibr44-0003319712455497">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conne</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stutz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vassalli</surname>
<given-names>JD</given-names>
</name>
</person-group>. <article-title>The 3' untranslated region of messenger RNA: a molecular ‘hotspot’ for pathology?</article-title> <source>Nat Med</source>. <year>2000</year>;<volume>6</volume>(<issue>6</issue>):<fpage>637</fpage>–<lpage>641</lpage>.</citation>
</ref>
<ref id="bibr45-0003319712455497">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cartegni</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Krainer</surname>
<given-names>AR</given-names>
</name>
</person-group>. <article-title>Listening to silence and understanding nonsense: exonic mutations that affect splicing</article-title>. <source>Nat Rev Genet</source>. <year>2002</year>;<volume>3</volume>(<issue>4</issue>):<fpage>285</fpage>–<lpage>298</lpage>.</citation>
</ref>
<ref id="bibr46-0003319712455497">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mousavinasab</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tahtinen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jokelainen</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men</article-title>. <source>Mol Genet Metab</source>. <year>2006</year>;<volume>87</volume>(<issue>2</issue>):<fpage>147</fpage>–<lpage>151</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>